# A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH

> **NCT00510406** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 919 (actual)

## Conditions studied

- Lower Urinary Tract Symptoms
- Prostatic Hyperplasia

## Interventions

- **DRUG:** tamsulosin hydrochloride
- **DRUG:** solifenacin succinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00510406
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 919 (ACTUAL)
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510406, "A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00510406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*